COVID-19 Impact on Global Immune Thrombocytopenia Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: C4219F4C0CADEN
QYResearch

Abstracts

This report focuses on the global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Amgen Inc.
• CSL Ltd.
• Horizon Therapeutics Plc
• Merck & Co., Inc.
• Novartis AG
• Rigel Pharmaceuticals Inc.
• ...

Market segment by Type, the product can be split into

• Thrombopoietin Receptor Agonists (TPO-RAs)
• Corticosteroids
• Intravenous Immunoglobins (IVIGs)
• Other Drugs

Market segment by Application, split into

• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Centers
• Academic Institutes and Research Organizations

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Immune Thrombocytopenia Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune Thrombocytopenia Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Thrombopoietin Receptor Agonists (TPO-RAs)
  1.4.3 Corticosteroids
  1.4.4 Intravenous Immunoglobins (IVIGs)
  1.4.5 Other Drugs
1.5 Market by Application
  1.5.1 Global Immune Thrombocytopenia Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Biotechnology and Pharmaceutical Companies
  1.5.3 Hospitals and Diagnostic Centers
  1.5.4 Academic Institutes and Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Immune Thrombocytopenia Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Immune Thrombocytopenia Drugs Industry
    1.6.1.1 Immune Thrombocytopenia Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Immune Thrombocytopenia Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Immune Thrombocytopenia Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Immune Thrombocytopenia Drugs Market Perspective (2015-2026)
2.2 Immune Thrombocytopenia Drugs Growth Trends by Regions
  2.2.1 Immune Thrombocytopenia Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Immune Thrombocytopenia Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Immune Thrombocytopenia Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Immune Thrombocytopenia Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Immune Thrombocytopenia Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Immune Thrombocytopenia Drugs Players by Market Size
  3.1.1 Global Top Immune Thrombocytopenia Drugs Players by Revenue (2015-2020)
  3.1.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Immune Thrombocytopenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immune Thrombocytopenia Drugs Market Concentration Ratio
  3.2.1 Global Immune Thrombocytopenia Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Immune Thrombocytopenia Drugs Revenue in 2019
3.3 Immune Thrombocytopenia Drugs Key Players Head office and Area Served
3.4 Key Players Immune Thrombocytopenia Drugs Product Solution and Service
3.5 Date of Enter into Immune Thrombocytopenia Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Immune Thrombocytopenia Drugs Historic Market Size by Type (2015-2020)
4.2 Global Immune Thrombocytopenia Drugs Forecasted Market Size by Type (2021-2026)

5 IMMUNE THROMBOCYTOPENIA DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)
5.2 Global Immune Thrombocytopenia Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Immune Thrombocytopenia Drugs Market Size (2015-2020)
6.2 Immune Thrombocytopenia Drugs Key Players in North America (2019-2020)
6.3 North America Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
6.4 North America Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Immune Thrombocytopenia Drugs Market Size (2015-2020)
7.2 Immune Thrombocytopenia Drugs Key Players in Europe (2019-2020)
7.3 Europe Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
7.4 Europe Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Immune Thrombocytopenia Drugs Market Size (2015-2020)
8.2 Immune Thrombocytopenia Drugs Key Players in China (2019-2020)
8.3 China Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
8.4 China Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Immune Thrombocytopenia Drugs Market Size (2015-2020)
9.2 Immune Thrombocytopenia Drugs Key Players in Japan (2019-2020)
9.3 Japan Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
9.4 Japan Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Immune Thrombocytopenia Drugs Market Size (2015-2020)
10.2 Immune Thrombocytopenia Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Immune Thrombocytopenia Drugs Market Size (2015-2020)
11.2 Immune Thrombocytopenia Drugs Key Players in India (2019-2020)
11.3 India Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
11.4 India Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Immune Thrombocytopenia Drugs Market Size (2015-2020)
12.2 Immune Thrombocytopenia Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Immune Thrombocytopenia Drugs Market Size by Type (2015-2020)
12.4 Central & South America Immune Thrombocytopenia Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen Inc.
  13.1.1 Amgen Inc. Company Details
  13.1.2 Amgen Inc. Business Overview and Its Total Revenue
  13.1.3 Amgen Inc. Immune Thrombocytopenia Drugs Introduction
  13.1.4 Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020))
  13.1.5 Amgen Inc. Recent Development
13.2 CSL Ltd.
  13.2.1 CSL Ltd. Company Details
  13.2.2 CSL Ltd. Business Overview and Its Total Revenue
  13.2.3 CSL Ltd. Immune Thrombocytopenia Drugs Introduction
  13.2.4 CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020)
  13.2.5 CSL Ltd. Recent Development
13.3 Horizon Therapeutics Plc
  13.3.1 Horizon Therapeutics Plc Company Details
  13.3.2 Horizon Therapeutics Plc Business Overview and Its Total Revenue
  13.3.3 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Introduction
  13.3.4 Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2015-2020)
  13.3.5 Horizon Therapeutics Plc Recent Development
13.4 Merck & Co., Inc.
  13.4.1 Merck & Co., Inc. Company Details
  13.4.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.4.3 Merck & Co., Inc. Immune Thrombocytopenia Drugs Introduction
  13.4.4 Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020)
  13.4.5 Merck & Co., Inc. Recent Development
13.5 Novartis AG
  13.5.1 Novartis AG Company Details
  13.5.2 Novartis AG Business Overview and Its Total Revenue
  13.5.3 Novartis AG Immune Thrombocytopenia Drugs Introduction
  13.5.4 Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2015-2020)
  13.5.5 Novartis AG Recent Development
13.6 Rigel Pharmaceuticals Inc.
  13.6.1 Rigel Pharmaceuticals Inc. Company Details
  13.6.2 Rigel Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.6.3 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Introduction
  13.6.4 Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020)
  13.6.5 Rigel Pharmaceuticals Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Immune Thrombocytopenia Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Immune Thrombocytopenia Drugs Revenue
Table 3. Ranking of Global Top Immune Thrombocytopenia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Thrombopoietin Receptor Agonists (TPO-RAs)
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Intravenous Immunoglobins (IVIGs)
Table 8. Key Players of Other Drugs
Table 9. COVID-19 Impact Global Market: (Four Immune Thrombocytopenia Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Immune Thrombocytopenia Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Immune Thrombocytopenia Drugs Players to Combat Covid-19 Impact
Table 14. Global Immune Thrombocytopenia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Immune Thrombocytopenia Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Immune Thrombocytopenia Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Immune Thrombocytopenia Drugs Market Share by Regions (2015-2020)
Table 18. Global Immune Thrombocytopenia Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Immune Thrombocytopenia Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Immune Thrombocytopenia Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Immune Thrombocytopenia Drugs Players
Table 25. Global Immune Thrombocytopenia Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Immune Thrombocytopenia Drugs Market Share by Players (2015-2020)
Table 27. Global Top Immune Thrombocytopenia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Thrombocytopenia Drugs as of 2019)
Table 28. Global Immune Thrombocytopenia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Immune Thrombocytopenia Drugs Product Solution and Service
Table 31. Date of Enter into Immune Thrombocytopenia Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Immune Thrombocytopenia Drugs Market Size Share by Type (2015-2020)
Table 35. Global Immune Thrombocytopenia Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Immune Thrombocytopenia Drugs Market Size Share by Application (2015-2020)
Table 37. Global Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Immune Thrombocytopenia Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 41. North America Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 43. North America Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 47. Europe Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 49. Europe Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 53. China Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 55. China Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 59. Japan Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 61. Japan Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 65. Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 71. India Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 73. India Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Immune Thrombocytopenia Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Immune Thrombocytopenia Drugs Market Share (2019-2020)
Table 77. Central & South America Immune Thrombocytopenia Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Immune Thrombocytopenia Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Immune Thrombocytopenia Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Immune Thrombocytopenia Drugs Market Share by Application (2015-2020)
Table 81. Amgen Inc. Company Details
Table 82. Amgen Inc. Business Overview
Table 83. Amgen Inc. Product
Table 84. Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 85. Amgen Inc. Recent Development
Table 86. CSL Ltd. Company Details
Table 87. CSL Ltd. Business Overview
Table 88. CSL Ltd. Product
Table 89. CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 90. CSL Ltd. Recent Development
Table 91. Horizon Therapeutics Plc Company Details
Table 92. Horizon Therapeutics Plc Business Overview
Table 93. Horizon Therapeutics Plc Product
Table 94. Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 95. Horizon Therapeutics Plc Recent Development
Table 96. Merck & Co., Inc. Company Details
Table 97. Merck & Co., Inc. Business Overview
Table 98. Merck & Co., Inc. Product
Table 99. Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 100. Merck & Co., Inc. Recent Development
Table 101. Novartis AG Company Details
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Product
Table 104. Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 105. Novartis AG Recent Development
Table 106. Rigel Pharmaceuticals Inc. Company Details
Table 107. Rigel Pharmaceuticals Inc. Business Overview
Table 108. Rigel Pharmaceuticals Inc. Product
Table 109. Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2015-2020) (Million US$)
Table 110. Rigel Pharmaceuticals Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Immune Thrombocytopenia Drugs Market Share by Type: 2020 VS 2026
Figure 2. Thrombopoietin Receptor Agonists (TPO-RAs) Features
Figure 3. Corticosteroids Features
Figure 4. Intravenous Immunoglobins (IVIGs) Features
Figure 5. Other Drugs Features
Figure 6. Global Immune Thrombocytopenia Drugs Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Hospitals and Diagnostic Centers Case Studies
Figure 9. Academic Institutes and Research Organizations Case Studies
Figure 10. Immune Thrombocytopenia Drugs Report Years Considered
Figure 11. Global Immune Thrombocytopenia Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Immune Thrombocytopenia Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Immune Thrombocytopenia Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Immune Thrombocytopenia Drugs Market Share by Players in 2019
Figure 16. Global Top Immune Thrombocytopenia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Thrombocytopenia Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Immune Thrombocytopenia Drugs Revenue in 2019
Figure 18. North America Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Immune Thrombocytopenia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Amgen Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 27. CSL Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CSL Ltd. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 29. Horizon Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Horizon Therapeutics Plc Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 31. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck & Co., Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 33. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis AG Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 35. Rigel Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Rigel Pharmaceuticals Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed